Woodline Partners LP acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 41,824 shares of the real estate investment trust's stock, valued at approximately $848,000.
Several other large investors have also recently added to or reduced their stakes in the company. Townsquare Capital LLC boosted its position in shares of Healthpeak Properties by 5.9% during the 4th quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock valued at $212,000 after acquiring an additional 584 shares in the last quarter. Exchange Traded Concepts LLC boosted its holdings in Healthpeak Properties by 10.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust's stock valued at $133,000 after purchasing an additional 598 shares in the last quarter. Huntington National Bank boosted its holdings in Healthpeak Properties by 3.0% during the fourth quarter. Huntington National Bank now owns 20,843 shares of the real estate investment trust's stock valued at $422,000 after purchasing an additional 613 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. grew its stake in shares of Healthpeak Properties by 4.4% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 16,649 shares of the real estate investment trust's stock valued at $337,000 after purchasing an additional 700 shares during the period. Finally, Commerzbank Aktiengesellschaft FI raised its holdings in shares of Healthpeak Properties by 3.9% in the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 21,002 shares of the real estate investment trust's stock worth $420,000 after buying an additional 797 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Stock Up 0.7%
Shares of DOC traded up $0.12 during midday trading on Thursday, hitting $17.53. The stock had a trading volume of 6,771,698 shares, compared to its average volume of 5,120,996. The firm has a market cap of $12.18 billion, a price-to-earnings ratio of 50.07, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a 50 day simple moving average of $18.28 and a two-hundred day simple moving average of $19.79. Healthpeak Properties, Inc. has a twelve month low of $16.64 and a twelve month high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the prior year, the company posted $0.45 earnings per share. The firm's revenue was up 15.9% on a year-over-year basis. On average, analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The business also recently disclosed a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be issued a $0.1017 dividend. This represents a dividend yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties's payout ratio is 305.00%.
Analysts Set New Price Targets
DOC has been the subject of a number of recent analyst reports. Evercore ISI dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Argus reiterated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Scotiabank decreased their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. Finally, Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Healthpeak Properties has a consensus rating of "Moderate Buy" and a consensus target price of $23.45.
Read Our Latest Research Report on DOC
Insider Activity
In other news, CEO Scott M. Brinker bought 11,337 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now owns 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John T. Thomas purchased 4,200 shares of the company's stock in a transaction on Monday, April 28th. The shares were purchased at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This represents a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 29,764 shares of company stock worth $521,909 in the last quarter. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.